Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2015 | Pages:
45 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Quark Pharmaceuticals, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Quark Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Quark Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Quark Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Quark Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Quark Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Quark Pharmaceuticals, Inc.'s pipeline products Reasons to Buy - Evaluate Quark Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Quark Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Quark Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Quark Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Quark Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Quark Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents
2 List of Tables 5 List of Figures 5 Quark Pharmaceuticals, Inc. Snapshot 6 Quark Pharmaceuticals, Inc. Overview 6 Key Information 6 Key Facts 6 Quark Pharmaceuticals, Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Quark Pharmaceuticals, Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 Quark Pharmaceuticals, Inc. - Pipeline Products Glance 14 Quark Pharmaceuticals, Inc. - Late Stage Pipeline Products 14 Phase III Products/Combination Treatment Modalities 14 Quark Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 15 Phase II Products/Combination Treatment Modalities 15 Quark Pharmaceuticals, Inc. - Early Stage Pipeline Products 16 Preclinical Products/Combination Treatment Modalities 16 Discovery Products/Combination Treatment Modalities 17 Quark Pharmaceuticals, Inc. - Drug Profiles 18 QPI-1002 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 QPI-1007 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 PF-655 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 QPHL-2 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 QPLI-1 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 QPAL-1 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 QPAL-2 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 QPCO-1 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 QPCP-1 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 QPEN-1 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 QPEN-2 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 QPHL-1 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 QPHL-3 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 QPLI-2 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 QPNR-1 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Quark Pharmaceuticals, Inc. - Pipeline Analysis 36 Quark Pharmaceuticals, Inc. - Pipeline Products by Target 36 Quark Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 37 Quark Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 38 Quark Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 39 Quark Pharmaceuticals, Inc. - Recent Pipeline Updates 40 Quark Pharmaceuticals, Inc. - Dormant Projects 42 Quark Pharmaceuticals, Inc. - Locations And Subsidiaries 43 Head Office 43 Other Locations & Subsidiaries 43 Appendix 44 Methodology 44 Coverage 44 Secondary Research 44 Primary Research 44 Expert Panel Validation 44 Contact Us 44 Disclaimer 45
List of Tables
Quark Pharmaceuticals, Inc., Key Information 6 Quark Pharmaceuticals, Inc., Key Facts 6 Quark Pharmaceuticals, Inc. - Pipeline by Indication, 2015 8 Quark Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 10 Quark Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 11 Quark Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2015 12 Quark Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2015 13 Quark Pharmaceuticals, Inc. - Phase III, 2015 14 Quark Pharmaceuticals, Inc. - Phase II, 2015 15 Quark Pharmaceuticals, Inc. - Preclinical, 2015 16 Quark Pharmaceuticals, Inc. - Discovery, 2015 17 Quark Pharmaceuticals, Inc. - Pipeline by Target, 2015 36 Quark Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015 37 Quark Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 38 Quark Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 39 Quark Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015 40 Quark Pharmaceuticals, Inc. - Dormant Developmental Projects,2015 42 Quark Pharmaceuticals, Inc., Other Locations 43
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
